Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection

Journal of Pathology

Volumn 209, Issue 3, 2006, Pages 400-410

  Sorrentino, C ^a   Scarinci, A ^b   D'Atuono, T ^a   Piccirilli, M ^a   Di Nicola, M ^a   Pasquale, M ^b   Di Iorio, C ^b   Di Carlo, E ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Ospedale 'SS Annunziata'   (Italy)

Author keywords

Cytokines; Electron microscopy; Immunohistochemistry; Leukocytes; Transplatation

Indexed keywords

AZATHIOPRINE; CD20 ANTIGEN; CD69 ANTIGEN; CD94 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 12; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CARDIAC GRAFT REJECTION; CELL INFILTRATION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DIGITAL IMAGING; DISEASE COURSE; ELECTRON MICROSCOPY; ENDOCARDIAL BIOPSY; ENDOCARDIUM; FEMALE; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MUSCLE ATROPHY; NATURAL KILLER CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; T LYMPHOCYTE; ULTRASTRUCTURE;

ADULT; AGED; B-LYMPHOCYTES; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; ENDOCARDIUM; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; INTERLEUKIN-12; KILLER CELLS, NATURAL; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RECURRENCE;

EID: 33745698743     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1980     Document Type: Article

References (41)

1. Billingbam ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990;9:587-593.
2. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005;24:1710-1720.
3. Gallo P, Agozzino L, Angelini A, Arbustini E, Bartoloni G, Bernucci P, et al. Causes of late failure after heart transplantation: a ten-year survey. J Heart Lung Transplant 1997;16:1113-1121.
4. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Deng MC, Keck BM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J Heart Lung Transplant 2005;24:945-955.
5. Wong BW, Rahmani M, Rezai N, McManus BM. Progress in heart transplantation. Cardiovasc Pathol 2005;14:176-180.
6. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
7. McGoon MD, Fronty RP. Techniques of immunosuppression after cardiac transplantation. Mayo Clin Proc 1992;67:586-595.
8. Di Carlo E, Cappello P, Sorrentino C, D'Antuono T, Pellic-ciotta A, Giovarelli M, et al. Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway. J Pathol 2005;205:82-91.
9. Zhang H, Li Y, Peng T, Aasa M, Zhang L, Yang Y, et al. Localization of enteroviral antigen in myocardium and other tissues from patients with heart muscle disease by an improved imnumohistochemical technique. J Histochem Cytochem 2000;48:579-584.
10. Plachter B, Nordin M, Wirgart BZ, Mach M, Stein H, Grillner L, et al. The DNA-binding protein P52 of human cytomegalovirus reacts with monoclonal antibody CCH2 and associates with the nuclear membrane at late times after infection. Virus Res 1992;24:265-276.
11. Ganne V, Siddiqi N, Kamaplath B, Chang CC, Cohen EP, Bresnaban BA, et al. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder. Clin Transplant 2003;17:417-422.
12. Jacobs JJ, Lehe C, Cammans KD, Yoneda K, Das PK, Elliott GR. An automated method for the quantification of immunostained human Langerhans cells. J Immunol Methods 2001;247:73-92.
13. Rodriguez ER, Skojec DV, Tan CD, Zachary AA, Kasper EK, Conte JV, et al. Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant 2005;5:2778-2785.
14. Stewart SC, Cary NRB, Goddard MJ, Billingham ME. Atlas of Biopsy Pathology for Heart and Lung Transplantation. Arnold: London,2000;18.
15. Michaels PJ, Kobashigawa J, Laks H, Azarbal A, Espejo ML, Chen L, et al. Differential expression of RANTES chemokine, TGF-beta, and leukocyte phenotype in acute cellular rejection and quilty B lesions. J Heart Lung Transplant 2001;20:407-416.
16. Marboe CC, Billingham M, Eisen H, Deng MC, Baron H, Mehra M, et al. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant 2005;24(Suppl):S219-S226.
17. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005;5:807-817.
18. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, et al. The interieukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1999;16:495-521.
19. Filatenkov AA, Jacovetty EL, Fischer UB, Curtsinger JM, Mescher MF, Ingulli E. CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of tolerance. J Immunol 2005;174:6909-6917.
20. Tiao MM, Lu L, Tao R, Wang L, Fung JJ, Qian S. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity. Ann Surg 2005;241:497-505.
21. Hara M, Kingsley Cl, Niimi M, Read S, Turvey SE, Bushell AR, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001;166:3789-3796.
22. David A, Chetritt J, Guillot C, Tesson L, Heslan JM, Cuturi MC, et al. Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats. Gene Ther 2000;7:505-510.
23. Van Hoffen E, Van Wichen D, Stuij I, De Jonge N, Klopping C, Lahpor J, et al. In situ expression of cytokines in human heart allografts. Am J Pathol 1996;149:1991-2003.
24. van Besouw NM, Zuijderwijk JM, Vaessen LM, Balk AH, Maat AP, van der Meide PH, eta[. The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantation. Clin Exp Immunol 2005;141:534-540.
25. Meiser BM, Groetzner J, Kaczmarek I, Landwehr P, Muller M, lung S, et al. Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? Transplantation 2004;78:591-598.
26. Geijtenbeek TB, Engering A, Van Kooyk Y. DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology. J Leukocyte Biol 2002;71:921-931.
27. van Kooyk Y, Geijtenbeek TB. A novel adhesion pathway that regulates dendritic cell trafficking and T cell interactions. Immunol Rev 2002;186:47-56.
28. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000;192:1213-1222.
29. Te Velde AA, van Kooyk Y, Braat H, Hommes DW, Dellemijn TA, Slors JF, et al. Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur J Immunol 2003;33:143-151.
30. Duperrier K, Velten FW, Bohlender J, Demory A, Metharom P, Goerdt S. Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes. Mol Immunol 2005;42:1531-1540.
31. Yu DT, Clements PJ, Paulus HE, Peter JB, Levy J, Barnett EV. Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest 1974;53:565-571.
32. Wasowska BA, Zheng XX, Strom TB, Kupieck-Weglinski JW. Adjunctive rapamycin and CsA treatment inhibits monocyte/macrophage associated cytokines/chemokines in sensitized cardiac graft recipients. Transplantation 2001;71:1179-1183.
33. Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, Masek M, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003;349:125-138.
34. Robson NC, Beacock-Sharp H, Donachie AM, Mowat AM. The role of antigen-presenting cells and interleukin-12 in the priming of antigen-specific CD4+ T cells by immune stimulating complexes. Immunology 2003;110:95-104.
35. Giomarelli P, Scolletta S, Borrelli E, Biagioli B. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg 2003;76:117-123.
36. Azzawi M, Hasleton PS, Grant SC, Stewart JP, Hutchinson IV. Interleukin-10 in human heart transplantation: an in situ hybridization study. The Manchester Transplant Cytokine Group. J Heart Lung Transplant 1995;14:519-528.
37. Di Carlo E, Coletti A, Modesti A, Giovarelli M, Forni G, Musiani P. Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection. Eur Cytokine Netw 1998;9:61-68.
38. Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM. The dual role of IL-10. Trends Immunol 2003;24:36-43.
39. Bielawska-Pohl A, Crola C, Caignard A, Gaudin C, Dus D, Kieda C, et al. Human NK cells lyse organ-specific endothelial cells: analysis of adhesion and cytotoxic mechanisms. J Immunol 2005;174:5573-5582.
40. Uehara S, Chase CM, Kitchens WH, Rose HS, Colvin RB, Russell PS, et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005;175:3424-3430.
41. Petersson E, Qi Z, Ekberg H, Ostraat O, Dohlsten M, Hedlund G. Activation of alloreactive natural killer cells is resistant to cyclosporine. Transplantation 1997;63:1138-1144.